InvestorsHub Logo

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
squidster PremiumMember
03/27/24 8:44 PM
profile icon
squidster PremiumMember
03/27/24 8:29 PM
profile icon
retired early Free
03/27/24 12:45 PM
profile icon
retired early Free
03/27/24 10:30 AM
profile icon
work-n-hard PremiumMember
03/27/24 8:46 AM
profile icon
EHRjunkie Free
03/27/24 7:28 AM
profile icon
squidster PremiumMember
03/26/24 7:50 PM
profile icon
squidster PremiumMember
03/26/24 7:48 PM
profile icon
Aero-man Free
03/26/24 3:14 PM
Bullish
Bullish
profile icon
retired early Free
03/26/24 9:37 AM
profile icon
bige777 Free
03/25/24 11:13 AM
Bullish
Bullish
profile icon
EHRjunkie Free
03/25/24 10:18 AM
profile icon
EHRjunkie Free
03/25/24 10:18 AM
profile icon
EHRjunkie Free
03/25/24 10:17 AM
profile icon
EHRjunkie Free
03/25/24 10:16 AM
profile icon
Aero-man Free
03/23/24 2:48 PM
Bullish
Bullish
profile icon
work-n-hard PremiumMember
03/22/24 1:55 PM
profile icon
squidster PremiumMember
03/22/24 1:50 PM
profile icon
work-n-hard PremiumMember
03/21/24 4:03 PM
profile icon
retired early Free
03/21/24 1:49 PM
profile icon
work-n-hard PremiumMember
03/21/24 12:58 PM
profile icon
retired early Free
03/20/24 10:57 AM
Bullish
Bullish
profile icon
Aero-man Free
03/19/24 3:03 PM
profile icon
retired early Free
03/19/24 11:51 AM
profile icon
retired early Free
03/18/24 12:07 PM
profile icon
gkare Free
03/14/24 10:24 AM
profile icon
sundoctor Free
03/05/24 9:43 AM
profile icon
gkare Free
03/01/24 2:07 PM
profile icon
squidster PremiumMember
02/27/24 6:41 PM
profile icon
Dinesh Malta Free
02/27/24 12:41 PM
profile icon
docsetc Free
02/26/24 12:04 PM
profile icon
squidster PremiumMember
02/23/24 9:31 PM
Bearish
Bearish
profile icon
work-n-hard PremiumMember
02/23/24 3:18 PM
profile icon
Aero-man Free
02/22/24 12:51 PM
Bullish
Bullish
profile icon
sundoctor Free
02/22/24 8:07 AM
profile icon
sundoctor Free
02/21/24 8:18 PM
profile icon
trunkmonk Free
02/21/24 11:48 AM
profile icon
squidster PremiumMember
02/20/24 7:27 PM
profile icon
squidster PremiumMember
02/20/24 7:22 PM
profile icon
gkare Free
02/20/24 6:09 PM
profile icon
work-n-hard PremiumMember
02/20/24 4:12 PM
profile icon
gkare Free
02/16/24 7:39 PM
Bullish
Bullish
profile icon
squidster PremiumMember
02/16/24 7:08 PM
profile icon
Aero-man Free
02/16/24 1:12 PM
profile icon
retired early Free
02/16/24 9:39 AM
profile icon
bige777 Free
02/16/24 5:43 AM
Bullish
Bullish
profile icon
gkare Free
02/15/24 7:35 PM

Halberd Corp (HALB) RSS Feed

Followers
288
Posters
Posts (Today)
0
Posts (Total)
26157
Created
02/15/11
Type
Free
Moderators squidster EHRjunkie

(responsible mod: Bill Moynihan)

 

HALBERD CORPORATION 


                                                                                   




https://halberdcorporation.com/

                
Email: support@halberdcorporation.com

HALB Security Details - https://www.otcmarkets.com/stock/HALB/security


Share Structure

    Authorized Shares   -    800,000,000 - a/o 03/21/2024

Shares Outstanding  -  635,874,842 - a/o 03/21/2024

                          Float  -  280,542,712 - a/o 01/01/2024


 

 Halberd Corp. (OTC PINK:HALB), is a publicly traded company on the OTC Market, and is in full compliance with OTC Market reporting requirements.            

                                                                              
                                                                                      
Halberd holds the exclusive rights to 4 granted U.S. Patents, no. 9,216,386 no. 8,758,287 and no. 11,186,629, no. 8,865,733 

 

 

 Halberd Corporation is a biotechnology company and with its partners (Dr. Qiang Shawn Chen and his team at Arizona State University; Dr. William Sturrus and his team at Youngstown State University; Dr. Richard Carr and his team at Mississippi State University), is developing an extra-corporeal (out of the body) treatment against PTSD, CTE, Alzheimer's Disease and other virusses and diseases. With the use of antibodies the disease antigens is targeted. Using radiofrequency / laser technology the "antibody-metallic moiety-antigens complex" is destroyed/eradicated. All based on 4 granted patents and 22 pending provisional/non-provisional (some PCT) patent applications.

2024: In close cooperation with partner (revenue sharing agreement in place) AthenaGTX, Halberd Corp is working on contracts from the military, to develop treatments to tackle Traumatic Brain Injury/TBI (patent pending nasal spray) and Post Traumatic Stress Syndrome/PTSD (patented Low-Dose-Naltrexone product).
                                                                                                                                                                                                 

Halberd Corporation Successfully Establishes Disease Eradication Proof-of-Concept - "Never Before Accomplished"


https://www.accesswire.com/652434/Halberd-Corporations-Proprietary-Technology-for-Alzheimers-Disease-Enters-Stage-4-of-7-Stage-Process
 

CEO William Hartman: "The principal competitive Alzheimer's drug treatment available today eliminates 5-15% of Beta Amyloid after one month of treatment costing over $50,000 per year. Halberd's extracorporeal process eradicates 100% within just 10 minutes."





                                                                                                                                                                                    


 

JACKSON CENTER, PA / ACCESSWIRE / March 14, 2023 / Halberd Corporation (OTC PINK:HALB) is scheduled to meet with Center of Disease Control (CDC) representatives to discuss Halberd's incredible success in eradicating multiple strains of antibiotic resistant (AR) E. coli bacteria and Candida auris samples previously provided by the CDC. 


JACKSON CENTER, PA / ACCESSWIRE / September 6, 2023 / Halberd Corporation's (OTC PINK:HALB) research at Mississippi State University (MSU) has shown significant reduction in two key markers of traumatic brain injury (TBI) in early testing of Halberd's patent-pending nasal spray to mitigate the effects of TBI. Anecdotal data in preliminary testing reveals a 20% reduction in Neuron Specific Enolase and a 50% reduction in the levels of Glial Fibrillary Acid Protein compared to the control group.


JACKSON CENTER, PA / ACCESSWIRE / September 20, 2023 / Halberd Corporation (OTC PINK:HALB) and Athena GTX, Inc, of Johnston, Iowa commenced collaboration on critical development of submissions for government contracts seeking proposals for the detection and treatment of traumatic brain injury (TBI). The initial focus will be on accelerating and fine-tuning Halberd's proprietary nasal spray for suppressing the effects of traumatic brain injury (TBI).

JACKSON CENTER, PA / ACCESSWIRE / December 13, 2023 / Halberd Corporation 
(OTC PINK:HALB) and CrodenHealth.com of Canada agree to produce, market, sell and distribute Halberd's patented low dose naltrexone combo product(s) worldwide. The agreement also allows CrodenHealth.com right of first refusal regarding similar rights to future products in Halberd's development pipeline.

JACKSON CENTER, PA / ACCESSWIRE / January 10, 2024 / 
Halberd Corporation 
(OTC-PINK:HALB) is thrilled to declare the formalization of a profitable revenue-sharing accord with Athena GTX, Inc., of Johnston, Iowa, (www.athenagtx.com). Athena GTX is a private enterprise specializing in providing medical care solutions tailored for first responders in both civilian and government sectors.





                      
     

___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

 




 

 

 
 

 

 
 

 

 

Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
HALB Latest News
  • No Recent News Available for this company!
New Post